✨ Your Portfolio is fetched and updated from zerodha.
Nano

Aarey Drugs & Pharmaceuticals Ltd.

AAREYDRUGS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹187 Cr.
P/E
45.09

Aarey Drugs & Pharmaceuticals Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
187 Cr
PE
PE
45.09
Prom Holding
Prom Holding
44.80 %
ROE (%)
ROE (%)
3.53
ROCE (%)
ROCE (%)
7.11
Div Yield (%)
Div Yield (%)
-
Sales
Sales
449 Cr
OPM (%)
OPM (%)
0.76 %
Debt to Equity
Debt to Equity
0.24
View more
Edit Ratio's
About
Aarey Drugs & Pharmaceuticals Ltd.is engaged in the manufacturing of drugs and intermediates s… Read more
Low
40
52W Range
High
70
  • Aarey Drugs & Pharma
  • IndoAmerican Advance
  • Kimia Biosciences

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Aarey Drugs & Pharmaceuticals Ltd. Business

Aarey Drugs & Pharmaceuticals Ltd. specializes in manufacturing drugs and intermediates like metronidazole and nitro imidazole. Their product focus areas include Allergy, Dermatology, and Infectious Diseases.

Aarey Drugs & Pharma major competitors are IndoAmerican Advance, Kimia Biosciences, Quest Laboratories, Vaishali Pharma, Coral Laboratories, Krebs Biochem.&Inds, Astonea Labs.
Market Cap of Aarey Drugs & Pharma is ₹178 Crs.
While the median market cap of its peers are ₹168 Crs.

Aarey Drugs & Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Aarey Drugs & Pharma is 2.81 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice
Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material